Get your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
152 Doctors Online

By proceeding, I accept the Terms and Conditions

Dr. Andrew Rynne
Dr. Andrew Rynne

Family Physician

Exp 50 years

HCM Blog Instant Access to Doctors
HCM BlogQuestions Answered
HCM Blog Satisfaction
Article Home Children's Health Kallmann Syndrome

Kallmann Syndrome

Kallmann syndrome rare inherited condition characterized by hypogonadism (decreased functioning of the glands that produce sex hormones), eunuchoidism and impaired or absent sense of smell.


Kallmann syndrome is also called hypothalamic hypogonadism, familial hypogonadism with anosmia, and hypogonadotropic hypogonadism based on the mechanism.

Kallmann syndrome is a form of secondary hypogonadism, reflecting that the primary cause of the defect in sex-hormone production lies within the pituitary and hypothalamus rather than a physical defect of the testes or ovaries.

Signs and symptoms

  • Reduced sense of smell/ absent sense of smell
  • Progressive loss of vision and color blindness
  • Optic atrophy and nerve deafness
  • Mirror movement disorder
  • Renal agenesis
  • Delayed puberty in females (primary amenorrhea), lack of secondary sexual characteristics (breast development)
  • Dyspareunia- pain at the time intercourse
  • Delayed puberty in malesmicropenis and cyrptorchidism
  • Decreased libido and erectile dysfunction- Infertility
  • Osteoporosis


  • Kallmann syndrome can be inherited as an X-linked recessive trait, in which case there is a defect in the KAL1 gene, which maps to chromosome Xp22
  • Mutations of the DAX1 gene lead to X-linked idiopathic hypogonadotropic hypogonadism.
  • Loss-of-function mutations of the gene encoding FGFR1 have been described in autosomal dominant Kallmann syndrome.


  • Male infertility
  • Midline facial defect
  • Amenorrhea
  • Nystagmus
  • Female infertility
  • Holoprosencephaly
  • Hypogonadotropic hypogonadism



Tests and diagnosis

Imaging studies

  • MRI brain
  • 2D- Echo
  • Ultrasound – kidney
  • DEXA scan


Androgen replacement in males with Kallmann syndrome restores libido, erectile function, and well-being.

In addition, androgen replacement promotes the development of secondary sex characteristics (eg, facial, axillary, and pubic hair) and increases muscle strength.

Either parenteral or transdermal testosterone is the drug of choice for androgen replacement.

Estrogen replacement therapy (conjugated estrogens and estriol) in females with Kallmann syndrome promotes the development of secondary sex characteristics, including breast development and menstrual function, and it may prevent osteoporosis.

Oral contraceptives may be used as replacement therapy in young women.

Pulsatile administration of gonadotropin (GnRH) by subcutaneous or preferably intravenous infusion restores pituitary-gonadal axis function and fertility in the majority of people with Kallmann syndrome